Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing

Sponsor
Indiana University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03271580
Collaborator
(none)
28
1
55
0.5

Study Details

Study Description

Brief Summary

The purpose of this study is to learn more about biofilm and to see how it affects diabetic wounds. A biofilm can occur if a chronic infection causes bacteria to grow in a slime enclosed group. This grouping of bacteria is called a biofilm.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Finger prick test for HbA1c measurement
  • Procedure: Punch Biopsy
  • Other: Vac Sponge Collection
  • Other: Ankle Brachial Index

Detailed Description

There is one study visit with a 14-week follow-up that will take place during the participants standard of care visit at the Indiana University Health Comprehensive Wound Center (CWC). The following procedures will take place once your appointment has been completed:

  • Informed consent will be signed (if not previously signed)

  • A hemoglobin A1c drawn will be taken by research personnel, if one has not been done within the last 90 days to check your average blood sugar level.

  • An Ankle Brachial Index (ABI) will be obtained if the participant has a leg wound. This is to ensure that participants have adequate blood flow to your wound. This is a non-invasive test which measures blood pressure in both of the participants arms and ankles.

  • Demographics (such as your name and address and phone number, age), medical history, current medications, current standard of care labs, and wound data (measurements, cause of the wound, wound culture, assessments, treatments, and duration) will be recorded. The participant's medical record number will also be recorded.

  • A photo of the wound site will be taken.

  • Wound Vac Collection - The wound vac sponge will be collected (waste by product of the therapy) by the research staff.

  • An optional two 3 mm punch tissue biopsies will be obtained from the participant's provider. To perform the biopsy, the area surrounding the wound will first be numbed using a local anesthetic agent that will be injected at the wound site. Then, a pencil-like instrument will be used to remove a small, thin cylinder of tissue. Each biopsy is about the size of this dot. After the tissue is removed, a sterile gauze will be placed on the area to stop any minor bleeding that may occur. The biopsies will be looked at in the laboratory to look at the microorganisms. You will not receive the results of the completed laboratory analysis. (Note: If two biopsies cannot be obtained per your physician's discretion, only one biopsy, debridement tissue (dead tissue that is removed from your wound) or no tissue will be obtained, and/or culture swabs (your wound will be swabbed with something like a Q-tip to collect cells to test for bacteria or other organisms in the wound) will be collected to test for infection.)

During the 14-week follow-up visit, research staff will review the participant's medical chart to determine the final status of the wound. If the participant does not return to the CWC at 14 weeks, the last CWC visit will be documented as the wound check follow-up. This does not require the participant to return for an extra study visit. This information will only be collected from their medical chart if available:

  • Final status of the wound (healing, not healing, healed)

  • Wound data (measurements), treatments, and any standard of care labs will be obtained

  • A photo of your wound from the medical chart will be obtained (if available)

Study Design

Study Type:
Observational
Anticipated Enrollment :
28 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing
Actual Study Start Date :
Feb 1, 2020
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Diabetic patients infected ulcers

Diabetic patients with HbA1c<9 with who have wound 4weeks or longer with infection with following interventions: Finger prick test for HbA1c measurement Punch biopsy VAC sponge collection Ankle brachial index

Diagnostic Test: Finger prick test for HbA1c measurement
HbA1c measurement with finger prick method

Procedure: Punch Biopsy
Wound site will be anaesthetized, by punch biopsy tissue will be collected, wound site will be monitored for bleeding(if bleeding Cautery will be used to stop bleeding).

Other: Vac Sponge Collection
NPWT sponge which is discarded as biological waste, will be collected for wound macrophage isolation

Other: Ankle Brachial Index
Blood pressure test

Diabetic patients non infected Ulcers

Diabetic patients with HbA1c<9 who have wound 4 weeks or longer without infection with following interventions: Finger prick test for HbA1c measurement Punch biopsy VAC sponge collection Ankle brachial index

Diagnostic Test: Finger prick test for HbA1c measurement
HbA1c measurement with finger prick method

Procedure: Punch Biopsy
Wound site will be anaesthetized, by punch biopsy tissue will be collected, wound site will be monitored for bleeding(if bleeding Cautery will be used to stop bleeding).

Other: Vac Sponge Collection
NPWT sponge which is discarded as biological waste, will be collected for wound macrophage isolation

Other: Ankle Brachial Index
Blood pressure test

Outcome Measures

Primary Outcome Measures

  1. Biofilm infection [14 Weeks]

    Biofilm Infection using SEM and RT PCR analysis

  2. macrophage phenotyping [14 Weeks]

    Wound macrophage phenotypes using flowcytometry, RTPCR and RNA Seq

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age 18 and above years old

  2. Willing and able to provide informed consent

  3. Willing and able to comply with protocol instructions, including biopsies and study visits

  4. Diabetics with an open wound

  5. Receiving Negative Wound Pressure Therapy (NPWT)

Exclusion Criteria:
  1. Inadequate arterial supply, as evidenced by any of the following (for wounds below the knee):

  2. TcOM < 30mmHg

  3. ABI < 0.7

  4. TBI < 0.6

  5. Women who are pregnant

Contacts and Locations

Locations

Site City State Country Postal Code
1 IU Health Methodist Hospital Indianapolis Indiana United States 46202

Sponsors and Collaborators

  • Indiana University

Investigators

  • Principal Investigator: Sashwati Roy, PhD, Indiana University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sashwati Roy, Professor, Indiana University
ClinicalTrials.gov Identifier:
NCT03271580
Other Study ID Numbers:
  • 1808802536
First Posted:
Sep 5, 2017
Last Update Posted:
Feb 23, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sashwati Roy, Professor, Indiana University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 23, 2022